Cerebral amyloid angiopathy (CAA) is a progressive cerebrovascular and
neurodegenerative disorder that is caused by the aberrant accumulation of soluble beta …

Is misfolding of the amyloid β peptide—the primary constituent of senile plaques in
Alzheimer disease and toxic cerebral vessel wall deposits in cerebral amyloid angiopathy …

Clinical characteristics of blood donors may affect short-and long-term outcomes of
transfusion recipients. The impact of donor sex and age on recipient outcomes have not …

Background and purpose Patients who underwent red blood cell (RBC) transfusion from
donors who later developed multiple spontaneous intracerebral hemorrhages (ICHs) have …

The Statistics Expert Group was convened at the request of the Infected Blood Inquiry to
provide estimates of the number of infections and deaths from blood-borne infections …

Background Identification and prevention of transfusion-transmitted disease is essential for
blood transfusion safety. However, current surveillance systems are largely driven by reports …

Cerebral amyloid angiopathy (CAA) is defined by the deposition of amyloid β (Aβ) in
cerebral vessel walls [1]. Until rather recently, two forms of CAA were known: sporadic CAA …

A priority for the International Journal of Stroke (IJS) is to highlight the global burden of
stroke. The worldwide epidemiology of stroke is regularly documented as part of the Global …

Platelets are anucleate blood cells traditionally associated with hemostasis but now
increasingly recognized for their multifaceted roles in immunity, inflammation, and tissue …

Dear Editor, Cerebral amyloid angiopathy (CAA) is caused by deposition of amyloid fibrils in
cerebral vessels, resulting in hemorrhagic events. Recently, it has been reported that …